Enzo Biochem Company Profile (NYSE:ENZ)

Analyst Ratings

Consensus Ratings for Enzo Biochem (NYSE:ENZ) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for Enzo Biochem (NYSE:ENZ)
Show:
DateFirmActionRatingPrice TargetActions
2/9/2016Dawson JamesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for Enzo Biochem (NYSE:ENZ)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/11/2016        
6/8/2016Q316($0.06)($0.04)$24.50 million$18.16 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q216($0.06)($0.07)$24.43 million$24.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/7/2015Q116($0.05)($0.05)$25.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/13/2015Q415($0.06)($0.06)$24.60 million$25.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/9/2015Q315($0.06)($0.07)$24.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2015Q215($0.09)($0.09)$23.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/9/2014Q114($0.08)($0.08)$24.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/9/2014($0.07)($0.06)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/9/2014Q314($0.09)($0.01)$22.80 million$24.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2014Q2($0.08)($0.09)$22.00 million$22.93 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/11/2013Q1($0.06)($0.07)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/16/2013Q413($0.08)$22.00 million$23.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/10/2013Q3 2013($0.15)$22.20 million$22.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Enzo Biochem (NYSE:ENZ)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.06)($0.06)($0.06)
Q3 20161($0.05)($0.05)($0.05)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Enzo Biochem (NYSE:ENZ)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Enzo Biochem (NYSE:ENZ)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Enzo Biochem (NYSE:ENZ)
DateHeadline
07/25/16 09:20 PMIs $8 Price Target Attainable For Enzo Biochem, Inc. (NYSE:ENZ)? - Investor Newswire
07/21/16 03:59 PMOption Market: Enzo Biochem Inc (NYSE:ENZ) Risk Hits An Elevated Level - CML News
07/20/16 05:07 PMEnzo Biochem Incorporated (NYSE:ENZ) Sellers Increased By 319.39% Their Shorts - Press Telegraph
07/20/16 06:37 AMEnzo Biochem Inc. ($0.01 Par Value) (ENZ) Hits New 52-week High During July 18 Session - Equities.com
07/19/16 11:20 AMETF’s with exposure to Enzo Biochem, Inc. : July 19, 2016 -
07/15/16 10:01 AMWhat's in Enzo Biochem, Inc. After Today's Huge Increase? - Press Telegraph
07/15/16 10:01 AMEnzo Biochem, Inc. (NYSE:ENZ) Updated Price Targets - FTSE News
07/15/16 10:01 AMEnzo Biochem Inc Stock Momentum Hits Strength - CML News
07/14/16 07:02 AMShort Interest Decreases By 30.7% For ENZ
07/11/16 07:35 AMStrength Seen in Heska (HSKA): Stock Jumps 5.7% in Session -
07/07/16 08:15 AMEnzo Biochem’s Life Sciences Unit Reaches $21 Million Patent Infringement Settlement in Delaware With Illumina, Inc. - [Business Wire] - Enzo Biochem, Inc. today announced that its subsidiary, Enzo Life Sciences, Inc., has reached and finalized a settlement with Illumina, Inc. that included a payment of $21 million to Enzo in an action brought in Delaware Federal District Court by Enzo alleging infringement of its U.S.
06/27/16 03:50 PMENZO BIOCHEM INC Files SEC form 8-K, Other Events -
06/27/16 03:48 PMEnzo Biochem : Added To Russell 2000, Russell 3000 and Russell Global Indexes
06/27/16 06:30 AMEnzo Biochem Added To Russell 2000, Russell 3000 and Russell Global Indexes - [Business Wire] - Enzo Biochem announced that it has been included in the broad-market Russell 3000® Index, Russell 2000® Index and Russell Global Index, which reconstituted after the market closed on Friday, June 24th.
06/25/16 03:40 PMEnzo Biochem, Inc. (NYSE:ENZ) Yearly Accounts Payable At $8.762 Millions - RealistInvestor.com
06/25/16 03:40 PMStrong Sell Calls Recommendations For Enzo Biochem, Inc. (NYSE:ENZ) At 0 - Investor Newswire
06/25/16 03:40 PMAnalysts Ranking Previews: Enzo Biochem, Inc. (NYSE:ENZ) , Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Street Updates
06/24/16 10:38 AMGlobal Osteonecrosis Pipeline Report 2016 - Therapeutics Review of Bone Therapeutics, Enzo Biochem, & K-Stemcell Co. - Research and Markets
06/24/16 08:55 AMEdited Transcript of ENZ earnings conference call or presentation 8-Jun-16 12:30pm GMT -
06/23/16 08:54 PMTraders Are Bullish Enzo Biochem, Inc. After Today's Gap Up - Press Telegraph
06/23/16 05:49 AMEnzo Biochem, Inc. (NYSE:ENZ) Current Analyst Ratings - Fiscal Standard
06/23/16 05:49 AMEnzo Biochem Inc. (NYSE:ENZ) Stock Momentum Hits Strength - CML News
06/22/16 03:58 PMOsteonecrosis Pipeline Market Global Stage and Molecule Types
06/22/16 08:33 AMOxidative Stress Assay 2016 Global Market Opportunities and Forecasts 2022
06/21/16 03:39 PMUveitis Treatment Market - Asia to Witness Fastest Growth by 2020
06/19/16 08:13 AMEnzo Biochem, Inc. (NYSE:ENZ) Accounts Payable Is $9.152 For The Quarter Ended 2016-04-30 - RealistInvestor.com
06/19/16 08:13 AMStrong Buy Calls Count For Enzo Biochem, Inc. (NYSE:ENZ) At 1 - Investor Newswire
06/15/16 08:34 AMEnzo Biochem Inc. ($0.01 Par Value) (ENZ) Drops 5.01% on June 13 - Equities.com
06/11/16 12:04 PMENZO BIOCHEM INC Financials -
06/10/16 07:21 AMEnzo Biochem Inc. ($0.01 Par Value) (ENZ) is Trading Higher on Unusual Volume for June 08 - Equities.com
06/09/16 07:56 AMEnzo Biochem (ENZ) Q3 2016 Results - Earnings Call Transcript - Seeking Alpha
06/09/16 07:56 AMEnzo Biochem Inc. ($0.01 Par Value) (ENZ) is Trading Lower on Unusual Volume for June 07 - Equities.com
06/08/16 04:00 PMBRIEF-Enzo Biochem Q3 non-gaap loss per share $0.04 - Reuters
06/08/16 04:00 PMEnzo Biochem Reports Fiscal Third Quarter Results - Business Wire (press release)
06/08/16 08:11 AMEnzo Biochem Reports Fiscal Third Quarter Results
06/08/16 07:01 AMENZO BIOCHEM INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure -
06/08/16 06:43 AMEnzo Biochem reports 3Q loss -
06/07/16 03:56 PMPseudomonas Diagnostic Testing Market Research Report : Forecast 2015 - 2021
06/07/16 03:56 PMResearch focused on the osteoporosis pipeline market review 2016
06/07/16 03:56 PMENZO BIOCHEM INC : Other Events (form 8-K)
06/07/16 03:56 PMEnzo Biochem Announces New York State Approval of New Women's Test Based on Proprietary Technology
06/03/16 03:25 PMEnzo Biochem Schedules Teleconference to Discuss Third Quarter 2016 Results Wednesday, June 8, 2016 at 8:30 AM E.T. - [Business Wire] - Enzo Biochem, Inc. , will hold a conference call to discuss fiscal 2016 third quarter results, Wednesday, June 8, 2016, at 8:30 AM E.T.
06/03/16 07:55 AMNew report examines the global central nervous system (cns) biomarkers market : global industry information, market size and forecast 2016 - Abastar MDX Inc, Thermo fisher scientific, Abiant Inc, EKFdiagnostics holdings Inc, Enzo biochem Inc, Acumen pharmaceuticals Inc, Adlyfe Inc, Alseres pharmaceuticals Inc, Apitope international, Aposense, Applied neurosolutions Inc, Avacta group plc ...
06/01/16 07:50 AMType 2 Diabetes Market Pipeline Covering 221 Companies for H1 2016 Reviewed in New Research Report - Inc, Enzo Biochem, Inc., Epichem Pty Ltd, Esperion Therapeutics, Inc., Eternygen GmbH, Euroscreen S.A., Evotec AG, F. Hoffmann-La Roche Ltd., FibroStatin SL, Flamel Technologies S.A., Foresee Pharmaceuticals, LLC, Generex Biotechnology Corporation ...
05/25/16 01:20 PMEnzo Biochem, Inc. (NYSE:ENZ) Closes At $6.17 - Investor Newswire - Enzo Biochem, Inc. (NYSE:ENZ) Closes At $6.17Investor NewswireYesterday, the stock of Enzo Biochem, Inc. (NYSE:ENZ) closed at $6.17 after opening at $6.21 and registering high of $6.38 and low of $6.00. The last price is $-0.12 off 1-year high of $6.47 and $4.09 away from low of $2.26 during same period. This ...Enzo Biochem Incorporated (NYSE:ENZ) Shorted Shares Increased 1.19% After Market SellingThe PostBroker Roundup For Enzo Biochem, Inc. (NYSE:ENZ)Share Trading Newsall 3 news articles »
05/23/16 04:07 PMETF’s with exposure to Enzo Biochem, Inc. : May 23, 2016 -
05/20/16 01:31 PMEnzo Biochem Inc. (ENZ) is Trading Higher on Unusual Volume for May 18 - Equities.com - Enzo Biochem Inc. (ENZ) is Trading Higher on Unusual Volume for May 18Equities.comEnzo Biochem Inc. (ENZ) experienced unusually high volume on May. 18, as the stock gained 0.48% to a closing price of $6.23. The stock saw 410,724 shares trade hands over the course of the day on 2,263 trades. Given that the stock's average daily ...Enzo Biochem, Inc. (NYSE:ENZ) Updated Broker Price TargetsShare Trading Newsall 2 news articles »
05/19/16 01:08 PMEnzo Biochem Inc. (ENZ) is Trading Higher on Unusual Volume for May 17 - Equities.com - Enzo Biochem Inc. (ENZ) is Trading Higher on Unusual Volume for May 17Equities.comEnzo Biochem Inc. (ENZ) experienced unusually high volume on May. 17, as the stock gained 1.81% to a closing price of $6.20. The stock saw 306,183 shares trade hands over the course of the day on 1,931 trades. Given that the stock's average daily ...
05/18/16 01:50 PMEnzo Biochem Inc. (ENZ) is Trading Higher on Unusual Volume for May 16 - Equities.com - Enzo Biochem Inc. (ENZ) is Trading Higher on Unusual Volume for May 16Equities.comEnzo Biochem Inc. (ENZ) experienced unusually high volume on May. 16, as the stock gained 0.66% to a closing price of $6.09. The stock saw 392,252 shares trade hands over the course of the day on 2,091 trades. Given that the stock's average daily ...Upgrades And Downgrades For Enzo Biochem, Inc. (NYSE:ENZ)Risers & FallersEnzo Biochem (ENZ) Announces $35M Patent Infringement Settlement with Life Technologies (TMO)StreetInsider.comLatest Analyst Ratings For Enzo Biochem, Inc. (NYSE:ENZ)Share Trading NewsEnterprise Leader -Finance Dailyall 10 news articles »
05/18/16 01:50 PMEnzo Biochem Inc. (ENZ) Hits New 52-week High During May 16 Session - Equities.com - Enzo Biochem Inc. (ENZ) Hits New 52-week High During May 16 SessionEquities.comEnzo Biochem Inc. (ENZ) hit a new 52-week high yesterday, reaching a peak of $6.47 after opening at $6.10 and closing at $6.09 for a move of 0.66%. Hitting a new 52-week high is a notable milestone for any company, and it can mean a trading opportunity ...and more »

Social

About Enzo Biochem

Enzo Biochem logoEnzo Biochem, Inc. (Enzo) is an integrated life science and biotechnology company, which is engaged in the research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally. The Company operates through three segments: Enzo Life Sciences, Enzo Clinical Labs and Enzo Therapeutics. Enzo Life Sciences segment manufactures, develops and markets products and tools to clinical research, drug development and bioscience research customers around the world. Enzo Clinical Labs segment provides diagnostic services to the healthcare community. Enzo Therapeutics segment conducts research and development activities for therapeutic drug candidates.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: ENZ
  • CUSIP:
Key Metrics:
  • Previous Close: $6.97
  • 50 Day Moving Average: $6.08
  • 200 Day Moving Average: $5.21
  • P/E Ratio: 18.25
  • P/E Growth: 0.00
  • Market Cap: $322.46M
  • Beta: 1.61
  • Current Year EPS Consensus Estimate: $-0.23 EPS
  • Next Year EPS Consensus Estimate: $-0.18 EPS
Additional Links:
Enzo Biochem (NYSE:ENZ) Chart for Friday, July, 29, 2016